000 01388 a2200397 4500
005 20250518085042.0
264 0 _c20210616
008 202106s 0 0 eng d
022 _a1098-8823
024 7 _a10.1016/j.prostaglandins.2020.106428
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbma, Willem
245 0 0 _aLipoxin A
_h[electronic resource]
260 _bProstaglandins & other lipid mediators
_c08 2020
300 _a106428 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBronchial Hyperreactivity
_xchemically induced
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aLipoxins
_xpharmacology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aPyroglyphidae
_xdrug effects
650 0 4 _aReceptors, Serotonin
_xmetabolism
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aTrachea
_xdrug effects
650 0 4 _aTumor Necrosis Factor-alpha
_xpharmacology
650 0 4 _aUp-Regulation
_xdrug effects
700 1 _aNoreby, Malin
700 1 _aWheelock, Craig E
700 1 _aDahlén, Sven-Erik
700 1 _aAdner, Mikael
700 1 _aSäfholm, Jesper
773 0 _tProstaglandins & other lipid mediators
_gvol. 149
_gp. 106428
856 4 0 _uhttps://doi.org/10.1016/j.prostaglandins.2020.106428
_zAvailable from publisher's website
999 _c30646985
_d30646985